TurkoVac

TURKOVAC[1] (pronunciation: ['tɜ:rkəvæk]) (temporarily named as ERUCOV-VAC[2]) is a COVID-19 vaccine candidate developed by Health Institutes of Turkey and Erciyes University.

TURKOVAC
Vaccine description
TargetSARS-CoV-2
Vaccine typeInactivated
Clinical data
Other namesERUCOV-VAC
Routes of
administration		Intramuscular
Part of a series on the
COVID-19 pandemic
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Timeline
2019

2020

2021
Locations
By country and territory

By conveyance
International response

National responses
Medical response

Vaccines
Variants
Variants of concern

Other variants
Economic impact and recession

By country
Impacts
 COVID-19 portal

Clinical trials

In November 2020, TURKOVAC started on phase I trials with 44 participants in Turkey.[3]

In February 2021, TURKOVAC started on phase II trials with 250 participants in Turkey.[4]

In June, TURKOVAC started on phase III trials with 40,800 participants in Turkey.[5]

Authorization

The Turkish Minister of Health said 25 November 2021: that the vaccine has been approved for use in emergency cases [6]

References
  1. Cakmak BN (22 June 2021). "Turkey names home-grown COVID-19 jab Turkovac". Anadolu Agency.
  2. "Domestic COVID-19 jab Turkovac begins Phase 3 trials in Turkey". Daily Sabah. 22 June 2021. Retrieved 23 June 2021.
  3. Clinical trial number NCT04691947 for "Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)" at ClinicalTrials.gov
  4. Clinical trial number NCT04824391 for "Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19 " at ClinicalTrials.gov
  5. "Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine". ClinicalTrials.gov. 28 June 2021. NCT04942405. Retrieved 29 June 2021.
  6. "Sağlık Bakanı Koca: TURKOVAC için acil kullanım onayına müracaat edildi". Orta Doğu Haberleri (in Turkish). 25 November 2021. Retrieved 25 November 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.